Infectious Disease Testing Market in the US 2015-2019

About infectious disease testing
Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed with HIV infection and in the same year 26,688 people were diagnosed with AIDS. Early diagnosis and treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing, POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care.

Manufacturers are developing diagnostic tests that can provide results in just a few minutes. For example, Alere developed Alere BinaxNOW Influenza A&B Card, which can detect influenza A & B in 15 minutes.

Technavios analysts forecast the infectious disease testing market in the US to grow at a CAGR of 5.81% over the period 2014-2019.

Covered in this report
The report covers the current scenario and the growth prospects of the infectious disease testing market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of equipment and consumables from molecular diagnostics, POCT diagnostic devices, and immunodiagnostics, which are used to detect infectious diseases:

The market is segmented based on technology:
Molecular diagnostic test
POCT
Immunodiagnostic test

The POCT for infectious disease is further segmented based on application:
HIV
Respiratory
HAIs
Sexual health
Tropical diseases
Hepatitis

In addition, the market is segmented based on products:
Equipment
Consumables

Technavios report, Infectious Disease Testing Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the five key vendors in the market. The vendor landscape focuses on vendors that provide access to new technologies. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.

Key vendors
Abbott Diagnostics
Alere
Beckman Coulter Diagnostics
Roche
Siemens Healthcare

Other prominent vendors
Abaxis
Acon Laboratories
Avioq
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Chembio Diagnostic Systems
Clarity Diagnostics
EMD Millipore
Epitope Diagnostic
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
Life Technologies
Maxim Biomedical
Mindray
OraSure Technologies
Ortho Clinical Diagnostics
Quidel Corporation
Thermo Fisher Scientific
Trinity Biotech

Market driver
North America free trade agreement
For a full, detailed list, view our report

Market challenge
Medical device excise tax law
For a full, detailed list, view our report

Market trend
Development of innovative diagnostics initiatives
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?